PT Arwana Citramulia Tbk (IDX:ARNA)

Sage Therapeutics Balance Sheet

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	165,674	391,887	440,665	438,361	602,550	435,882
Short-Term Investments	-	-	-	144,000	-	-
Cash & Short-Term Investments	165,674	391,887	440,665	582,361	602,550	435,882
Cash Growth	-31.05%	-11.07%	-24.33%	-3.35%	38.24%	24.90%
Accounts Receivable	960,188	919,113	855,576	734,213	681,498	614,594
Other Receivables	2,791	2,065	1,699	878.78	953.03	1,414
Receivables	962,978	921,178	857,275	735,092	682,451	616,008
Inventory	187,973	165,688	254,512	257,588	160,231	126,784
Prepaid Expenses	2,870	1,172	513.91	2,343	4,395	3,685
Other Current Assets	32,832	26,324	20,896	24,342	1,323	807.41
Total Current Assets	1,352,328	1,506,250	1,573,862	1,601,725	1,450,951	1,183,165
Property, Plant & Equipment	1,148,232	1,106,010	1,007,122	945,338	766,150	767,223
Long-Term Deferred Tax Assets	23,913	22,542	21,550	19,522	22,279	17,635
Other Long-Term Assets	61,571	26,561	17,958	12,285	4,144	2,317
Total Assets	2,586,044	2,661,364	2,620,492	2,578,869	2,243,523	1,970,340
Accounts Payable	362,137	324,754	305,658	312,186	283,643	295,374
Accrued Expenses	193,046	191,649	165,469	153,526	210,769	198,148
Short-Term Debt	107,516	106,568	110,922	50,488	19,824	29,791
Current Portion of Long-Term Debt	-	-	13,065	-	-	-
Current Income Taxes Payable	23,046	27,438	22,057	48,802	81,728	61,319
Current Unearned Revenue	-	-	-	-	-	218.66
Other Current Liabilities	75,598	67,527	34,865	120,893	8,482	17,722
Total Current Liabilities	761,343	717,936	652,037	685,895	604,446	602,572
Long-Term Debt	-	-	48,994	-	-	-
Total Liabilities	830,353	783,822	765,455	745,695	670,353	665,402
Common Stock	91,768	91,768	91,768	91,768	91,768	91,768
Additional Paid-In Capital	5,752	5,752	5,752	5,752	5,752	661.79
Retained Earnings	1,792,046	1,891,705	1,775,632	1,733,056	1,477,298	1,223,974
Treasury Stock	-169,921	-145,583	-49,650	-26,504	-26,504	-32,366
Total Common Equity	1,719,646	1,843,643	1,823,503	1,804,073	1,548,315	1,284,037
Minority Interest	36,045	33,899	31,533	29,100	24,855	20,901
Shareholders' Equity	1,755,691	1,877,542	1,855,036	1,833,173	1,573,170	1,304,939
Total Liabilities & Equity	2,586,044	2,661,364	2,620,492	2,578,869	2,243,523	1,970,340
Total Debt	107,516	106,568	172,982	50,488	19,824	29,791
Net Cash (Debt)	58,159	285,319	267,683	531,872	582,727	406,091
Net Cash Growth	-12.19%	6.59%	-49.67%	-8.73%	43.50%	34.31%
Net Cash Per Share	8.14	39.66	36.84	73.15	80.17	55.76
Filing Date Shares Outstanding	7,054	7,093	7,237	7,271	7,271	7,256
Total Common Shares Outstanding	7,054	7,093	7,237	7,271	7,271	7,256
Working Capital	590,985	788,314	921,826	915,830	846,504	580,593
Book Value Per Share	243.79	259.92	251.98	248.11	212.94	176.97
Tangible Book Value	1,719,646	1,843,643	1,823,503	1,804,073	1,548,315	1,284,037
Tangible Book Value Per Share	243.79	259.92	251.98	248.11	212.94	176.97
Land	73,995	73,995	71,127	63,637	56,980	45,184
Buildings	577,233	558,091	535,176	446,673	429,828	394,187
Machinery	1,816,702	1,753,396	1,633,154	1,367,017	1,341,885	1,248,954
Construction In Progress	109,691	89,089	32,661	221,665	670	39,647

Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.